Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07594028
What this trial is testing

Phase I/II Study of SCTB41 Plus SCTB39-1with or Without Standard Therapy in Advanced Solid Tumours

Who this might be right for
Advanced Malignant Solid Tumor
Sinocelltech Ltd. 126
Testing effectiveness (Phase 2)UnknownNCT05862831
What this trial is testing

Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Advanced Solid Tumors
Biotheus Inc. 285
Early research (Phase 1)Looking for participantsNCT07705035
What this trial is testing

DBC-664 in Adult Patients With Solid Tumors

Who this might be right for
Malignant Germ Cell TumorLung AdenocarcinomaGastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma+3 more
Duboce Biopharmaceuticals, Inc. 210
Not applicableLooking for participantsNCT07510321
What this trial is testing

FL-261 Imaging for Cancer Diagnosis and Staging

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerHead & Neck Cancer+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Early research (Phase 1)UnknownNCT05277454
What this trial is testing

Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT

Who this might be right for
Advanced Malignant Solid TumorsTGCT
Hutchison Medipharma Limited 113
Early research (Phase 1)Active Not RecruitingNCT05914376
What this trial is testing

Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors

Who this might be right for
Advanced Solid Tumors
Hangzhou Converd Co., Ltd. 24
Early research (Phase 1)Ended earlyNCT04729725
What this trial is testing

SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439123
What this trial is testing

Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Very early researchLooking for participantsNCT05141474
What this trial is testing

Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors

Who this might be right for
Epithelial Tumors, MalignantMalignant Solid Tumor
Vall d'Hebron Institute of Oncology 10
Early research (Phase 1)Looking for participantsNCT06606990
What this trial is testing

Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers

Who this might be right for
Metastatic Malignant Solid Neoplasm
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Looking for participantsNCT07070232
What this trial is testing

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 1,438
Early research (Phase 1)UnknownNCT05775666
What this trial is testing

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumor
Peking University 87
Early research (Phase 1)Study completedNCT04617314
What this trial is testing

RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumor
RemeGen Co., Ltd. 67
Early research (Phase 1)Ended earlyNCT05098405
What this trial is testing

First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Molecular Partners AG 46
Testing effectiveness (Phase 2)Study completedNCT04082572
What this trial is testing

Pembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid Cancers

Who this might be right for
Locally Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT02029001
What this trial is testing

Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

Who this might be right for
Malignant Solid Neoplasms
Centre Leon Berard 900
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390865
What this trial is testing

Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 49
Testing effectiveness (Phase 2)Looking for participantsNCT07192107
What this trial is testing

MHB042C in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136
What this trial is testing

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06724263
What this trial is testing

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Recurrent Platinum-resistant Epithelial Ovarian CancerTriple Negative Breast Cancer (TNBC)Cervical Cancers+4 more
Tasly Biopharmaceuticals Co., Ltd. 120
Next Page